As of 10:30 AM on the 29th, Baxel Bio is trading at 113,500 KRW, down 3.98% from the previous day. This represents a 21.0% increase compared to March 11.
Over the past five days, individual investors have net sold 55,449 shares, while foreigners and institutions have net bought 67,725 shares and net sold 12,521 shares, respectively.
On March 25, Baxel Bio became a market topic with the headline 'Complete remission case reported in 'Vax-NK' Phase 2 clinical trial... ongoing and promising...'
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
